The following is a summary of “Receiving hemodialysis in Hispanic ethnic dense communities is associated with better adherence and outcomes among young patients: a retrospective analysis of the Dialysis Outcomes and Practice Patterns Study,”...
The following is a summary of “Receiving hemodialysis in Hispanic ethnic dense communities is associated with better adherence and outcomes among young patients: a retrospective analysis of the Dialysis Outcomes and Practice Patterns Study,”...
1. Compared with using only using a GLP-1 receptor agonist or an SGLT-2 inhibitor, combination therapy with both drug classes was associated with a reduced risk of major adverse cardiac events (MACEs) and serious renal events. 2. The risk of serious renal events...
THURSDAY, May 2, 2024 (HealthDay News) -- Use of sodium–glucose cotransporter-2 inhibitors (SGLT2is) is associated with a substantially lower risk for dialysis and cardiovascular disease in patients with type 2 diabetes (T2D) and stage 5 chronic kidney disease...
THURSDAY, May 2, 2024 (HealthDay News) -- A genome-wide association study meta-analysis, published online April 26 in Nature Genetics, has identified 63 susceptibility regions containing 108 independent risk loci for kidney cancer.Mark P. Purdue, Ph.D., from the...
The following is a summary of “Effect of a single small volume fluid bolus with balanced or un-balanced fluids on chloride and acid–base status: a prospective randomized pilot study (the FLURES-trial),” published in the March 2024 issue of Nephrology by Raes et al....
The following is a summary of “Dynamics and outcomes of AKI progression during the COVID-19 pandemic,” published in the March 2024 issue of Nephrology by Ratnayake et al. Patients associated with COVID-19 along with Acute Kidney Injury have a poor prognosis....
1. Compared with using only using a GLP-1 receptor agonist or an SGLT-2 inhibitor, combination therapy with both drug classes was associated with a reduced risk of major adverse cardiac events (MACEs) and serious renal events. 2. The risk of serious renal events...
THURSDAY, May 2, 2024 (HealthDay News) -- Use of sodium–glucose cotransporter-2 inhibitors (SGLT2is) is associated with a substantially lower risk for dialysis and cardiovascular disease in patients with type 2 diabetes (T2D) and stage 5 chronic kidney disease...
THURSDAY, May 2, 2024 (HealthDay News) -- A genome-wide association study meta-analysis, published online April 26 in Nature Genetics, has identified 63 susceptibility regions containing 108 independent risk loci for kidney cancer.Mark P. Purdue, Ph.D., from the...
The following is a summary of “Effect of a single small volume fluid bolus with balanced or un-balanced fluids on chloride and acid–base status: a prospective randomized pilot study (the FLURES-trial),” published in the March 2024 issue of Nephrology by Raes et al....
The following is a summary of “Dynamics and outcomes of AKI progression during the COVID-19 pandemic,” published in the March 2024 issue of Nephrology by Ratnayake et al. Patients associated with COVID-19 along with Acute Kidney Injury have a poor prognosis....
Earth Day provided a good moment to reflect on the climate, climate change, and, most importantly, how the climate directly impacts human health.
New injectable weight loss medications are highly sought-after, causing shortages. Prescribing should not solely depend on patient requests.
Empathy is a critical part of healthcare and is very much needed today, especially as mental health issues such as depression and anxiety continue to expand.
New injectable weight loss medications are highly sought-after, causing shortages. Prescribing should not solely depend on patient requests.
Health inequities pervade the healthcare system, making it crucial for physicians to reevaluate what data is being collected and who is collecting the data.
The right financial advisor can help physicians by answering questions including which accounts are the right fit or what insurance is appropriate.
Insights from the leaders in medical research, trending topics in clinical medicine, and perspectives from your colleagues.
Subscribe to our free Newsletters to receive weekly emails, and even get a laugh or two from our medical cartoons.